For research use only
| Cat No. | ABC-KH006Y |
| Product Type | Knockout Stable Cell Line |
| Cell Type | Monocyte |
| Species | Human |
| Host Cell | THP-1 |
| Source Organ | Peripheral Blood |
| Disease | Acute Monocytic Leukemia |
| Storage | Liquid Nitrogen |
GSDMD Knockout THP-1 Cell Line by AcceGen provides an essential model for studying pyroptosis, inflammasome activation, and inflammatory responses.
GSDMD Knockout THP-1 Cell Line is generated from human monocytic THP-1 cells through CRISPR/Cas9-mediated disruption of the Gasdermin D (GSDMD) gene, a key executor of pyroptosis that mediates inflammatory cell death through membrane pore formation. This knockout model exhibits defective pyroptotic cell death while maintaining typical THP-1 characteristics including suspension growth with round morphology and PMA-induced differentiation into macrophage-like cells. The cell line provides an essential tool for studying inflammasome signaling, inflammatory responses, and host-pathogen interactions, particularly in research involving NLRP3 inflammasome activation and IL-1β/IL-18 secretion. Maintained at low passage numbers (<P20) with stable genotype, the knockout efficiency is validated through genomic PCR, sequencing, and functional assays demonstrating impaired pyroptosis. The cell line has been rigorously tested and confirmed free of contamination from HIV-1, HBV, HCV, Syphilis, mycoplasma, fungi, yeast, and bacteria.
| Species | Human |
| Cat.No | ABC-KH006Y |
| Product Category | Transfected Stable Cell Lines |
| Size/Quantity | 1 vial |
| Cell Type | Monocyte |
| Growth Mode | Suspension |
| Shipping Info | Dry Ice |
| Growth Conditions | 37 ℃, 5% CO2 |
| Source Organ | Peripheral Blood |
| Disease | Acute Monocytic Leukemia |
| Biosafety Level | 1 |
| Storage | Liquid Nitrogen |
| Product Type | Knockout Stable Cell Line |
| Host Cell | THP-1 |
| Gene Info | GSDMD |
| Quality Control | All cells test negative for mycoplasma, bacteria, yeast, and fungi. |
The GSDMD Knockout THP-1 Cell Line is a genetically engineered human monocyte model with targeted disruption of the gasdermin D (GSDMD) gene, resulting in defective pyroptosis execution. This modification creates a valuable tool for studying inflammasome signaling, inflammatory cell death pathways, and cytokine release mechanisms. The cell line enables investigation of caspase-1-mediated immune responses while maintaining normal monocyte differentiation potential, providing insights into inflammatory diseases and host-pathogen interactions.